Corvus Pharmaceuticals Inc
NASDAQ: CRVS
$3.62
-$0.27 (-6.9%)
Closing Price on May 14, 2025
CRVS Stock Chart and Intraday Price
CRVS Stock Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 2023-12-31 |
| Market Cap | 88.17M USD |
| Shares Outstanding | 49,038,600 |
CRVS Articles
Tuesday's top analyst upgrades and downgrades included Applied Materials, Bill, Catalyst Pharmaceutical, CVS Health, Elastic, Hawaiian Electric Industries and Walmart.
Published:
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Published:
Wednesday afternoon's analyst upgrades and downgrades included American Water Works, Corvus Pharmaceuticals, ImmunoGen, Lennar, StoneCo and Vertex Energy.
Published:
Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Avaya, Canopy Growth, Corsair Gaming, Skyworks Solutions and Virgin Galactic.
Published:
Last Updated:
